Literature DB >> 23452891

Valvular osteoclasts in calcification and aortic valve stenosis severity.

Edit Nagy1, Per Eriksson, Mohamed Yousry, Kenneth Caidahl, Erik Ingelsson, Göran K Hansson, Anders Franco-Cereceda, Magnus Bäck.   

Abstract

BACKGROUND: Bone remodeling in calcified aortic valves is thought to originate from microfractures at multiple sites of the valve, at which osteoclasts and osteoblasts are recruited. The aim of the present study was to assess circulating mediators of bone homeostasis, correlate them to the severity of stenosis and explore the spatio-temporal distribution of bone turnover in different parts of calcified aortic valve tissue. METHODS AND
RESULTS: Plasma and explanted aortic valves were obtained from 46 patients undergoing aortic valve replacement surgery. Plasma levels of tartrate-resistant acid phosphatase (TRAP), receptor activator of nuclear-κB (RANK) ligand and Runt-related transcription factor 2 (Runx2/Cbfa1) exhibited a significant correlation to the severity of aortic stenosis. mRNA levels in normal, thickened and calcified parts of aortic valves assessed by quantitative real-time PCR were significantly elevated in calcified parts of valves for TRAP (5.08 ± 1.6-fold, P<0.001) RANK ligand (8.6 ± 4.2-fold, P<0.001) and RANK (1.98 ± 0.78-fold, P=0.015). In an age, gender and aortic valve anatomy-adjusted multivariable regression analysis the local transcript levels of TRAP correlated significantly with echocardiographic parameters quantifying stenosis severity in early stages, whereas the expression level of Runx2/Cbfa1 was a predictor of the stenosis severity in advanced stages.
CONCLUSIONS: These findings suggest a critical role of bone turnover as a determinant of aortic stenosis severity.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aortic valve stenosis; Biomarker; Echocardiography; Osteoblast; Osteoclast

Mesh:

Substances:

Year:  2013        PMID: 23452891     DOI: 10.1016/j.ijcard.2013.01.207

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  18 in total

1.  Circulating Osteogenic Progenitor Cells in Mild, Moderate, and Severe Aortic Valve Stenosis.

Authors:  Mohammed Al-Hijji; Nupoor Narula; Jason L Go; Sundeep Khosla; Maurice Enriquez-Sarano; Darrell Loeffler; Ryan Lennon; Lilach O Lerman; Amir Lerman
Journal:  Mayo Clin Proc       Date:  2019-04       Impact factor: 7.616

2.  Mineral metabolism disturbances are associated with the presence and severity of calcific aortic valve disease.

Authors:  Zhen-kun Yang; Chen Ying; Hong-yan Zhao; Yue-hua Fang; Ying Chen; Wei-feng Shen
Journal:  J Zhejiang Univ Sci B       Date:  2015-05       Impact factor: 3.066

3.  Mechanosensitive microRNA-181b Regulates Aortic Valve Endothelial Matrix Degradation by Targeting TIMP3.

Authors:  Jack M Heath; Joan Fernandez Esmerats; Lucky Khambouneheuang; Sandeep Kumar; Rachel Simmons; Hanjoong Jo
Journal:  Cardiovasc Eng Technol       Date:  2017-02-24       Impact factor: 2.495

Review 4.  Aortic Stenosis: New Insights in Diagnosis, Treatment, and Prevention.

Authors:  Saki Ito; Jae K Oh
Journal:  Korean Circ J       Date:  2022-10       Impact factor: 3.101

5.  Interferon-γ Released by Activated CD8+ T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves.

Authors:  Edit Nagy; Yang Lei; Eduardo Martínez-Martínez; Simon C Body; Florian Schlotter; Michael Creager; Alexander Assmann; Kamal Khabbaz; Peter Libby; Göran K Hansson; Elena Aikawa
Journal:  Am J Pathol       Date:  2017-04-19       Impact factor: 4.307

6.  RANKL Expression Is Increased in Circulating Mononuclear Cells of Patients with Calcific Aortic Stenosis.

Authors:  Marcello Rattazzi; Elisabetta Faggin; Elisa Bertacco; Roberta Buso; Massimo Puato; Mario Plebani; Martina Zaninotto; Davide Condotta; Giacomo Zoppellaro; Leopoldo Pagliani; Giuseppe Tarantini; Sabino Iliceto; Elisa Covolo; Giuseppe Faggian; Francesco Onorati; Mikhail Dodonov; Alessandro Daniotti; Paola Pantano; Zoran Olivari; Giovanni Benfari; Paolo Pauletto
Journal:  J Cardiovasc Transl Res       Date:  2018-05-17       Impact factor: 4.132

7.  Calcium Signaling Pathway Genes RUNX2 and CACNA1C Are Associated With Calcific Aortic Valve Disease.

Authors:  Sandra Guauque-Olarte; David Messika-Zeitoun; Arnaud Droit; Maxime Lamontagne; Joël Tremblay-Marchand; Emilie Lavoie-Charland; Nathalie Gaudreault; Benoit J Arsenault; Marie-Pierre Dubé; Jean-Claude Tardif; Simon C Body; Jonathan G Seidman; Catherine Boileau; Patrick Mathieu; Philippe Pibarot; Yohan Bossé
Journal:  Circ Cardiovasc Genet       Date:  2015-11-09

8.  OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-κB pathway.

Authors:  Mohamed Jalloul Nsaibia; Marie-Chloé Boulanger; Rihab Bouchareb; Ghada Mkannez; Khai Le Quang; Fayez Hadji; Deborah Argaud; Abdellaziz Dahou; Yohan Bossé; Marlys L Koschinsky; Philippe Pibarot; Benoit J Arsenault; André Marette; Patrick Mathieu
Journal:  Cardiovasc Res       Date:  2017-09-01       Impact factor: 10.787

Review 9.  Harnessing Single-Cell RNA Sequencing to Better Understand How Diseased Cells Behave the Way They Do in Cardiovascular Disease.

Authors:  Farwah Iqbal; Adrien Lupieri; Masanori Aikawa; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-17       Impact factor: 8.311

Review 10.  Biomechanical factors in the biology of aortic wall and aortic valve diseases.

Authors:  Magnus Bäck; T Christian Gasser; Jean-Baptiste Michel; Giuseppina Caligiuri
Journal:  Cardiovasc Res       Date:  2013-03-03       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.